Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

Contributed by: GlobeNewswire

Tags

Oncology

More Like This

Achilles Therapeutics Announces Strategic Update

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

Tracer Biotechnologies Announces Agreement for Next-Generation Cancer Monitoring for Drug Development

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

PR Newswire associated0

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform